Trial Profile
An Open-Label Prospective Cohort Study of JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 16 Apr 2024
Price :
$35
*
At a glance
- Drugs Smallpox vaccine (Primary)
- Indications Monkeypox
- Focus Therapeutic Use
- 08 Apr 2024 Planned End Date changed from 1 Aug 2023 to 31 Dec 2025.
- 08 Apr 2024 Planned primary completion date changed from 1 Aug 2023 to 31 Dec 2025.
- 02 May 2023 Number of treatment arms increased from 1 to 2 by the addition of Experimental: Intervention (Lyophilized Formulation) arm separately for the same drug.